Medical and Pharmaceutical Lung cancer isn’t just for smokers anymore: European study The study analyzed CT scans from over 10,000 participants and found at least one lung nodule in 42 per cent of them Joseph MortonOctober 2, 2024
Medical and Pharmaceutical Shattuck Labs plummets after dropping lead drug candidate; lays off 40% of workers The biotech company is giving up on a leukemia drug and shifting focus to a bowel disease treatment Rowan DunneOctober 1, 2024
Medical and Pharmaceutical Onconetix shares go way up on Altos Ventures investment and stock split This oncology tech company has created the proprietary "Proclarix" blood test for diagnosing prostate cancer Rowan DunneSeptember 27, 2024
Medical and Pharmaceutical Mobile lung screening coming to remote Alberta communities next spring These trucks will complete thousands of CT scans and pulmonary function tests annually Rowan DunneSeptember 26, 2024
Health & Wellness World Lung Day highlights need for improved lung cancer screening rates Combatting air pollution and quitting smoking are also key themes Rowan DunneSeptember 25, 2024
Medical and Pharmaceutical Malaysia leads way in fight against lung diseases at World Cancer Congress The nation introduced a proposal to the WHO for global prioritization of lung health Rowan DunneSeptember 24, 2024
Medical and Pharmaceutical Wave Life Sciences shares pop 50% on positive clinical data for common type of muscular dystrophy Duchenne muscular dystrophy is a severe, progressive genetic disorder that primarily affects boys Joseph MortonSeptember 24, 2024
Medical and Pharmaceutical UK researchers conduct successful trials with saliva ‘dip’ lung cancer test Their findings have been published in the Royal Society of Chemistry's Analyst journal Rowan DunneSeptember 20, 2024
Medical and Pharmaceutical Fertility solutions provider Progyny tanks after losing top client Progyny's termination by the unnamed client in January will result in a 13% loss of revenue, approximately Rowan DunneSeptember 19, 2024
Medical and Pharmaceutical Edgewise Therapetics shares skyrocket on positive clinical trial returns The company stock rose 55 per cent after results of one dose show immediate results Joseph MortonSeptember 19, 2024